Skip to main content
. 2017 Mar 10;2017(3):CD008524. doi: 10.1002/14651858.CD008524.pub3

Albert 2003.

Methods Factorial design, individually‐randomized trial conducted in Dhaka, the capital city of Bangladesh
Participants Eligibility: children aged 2‐5 years of either sex, vitamin A deficiency (serum retinol level < 20 mg/dL; and nutritional status corresponding to a weight‐for‐age score that was 61% of the median National Center for Health Standards standard were included. Children who had received vitamin A supplementation during the preceding 6 months or who had a history of night blindness or sickness due to underlying illnesses such as diarrhoea or respiratory tract infections were excluded.
Sample: 256 children
Interventions 4 groups:
  1. Group I: vitamin A. Children were given 5 mL (200,000 IU) of vitamin A syrup once a week before administration of the first dose of the vaccine and received 5 mL of a placebo syrup every day for 42 days starting 3 weeks before administration of the first dose of vaccine and ending 1 week after the second dose of vaccine

  2. Group II: zinc. Children received 5 mL of zinc acetate syrup (containing 20 mg of elemental zinc) daily and a single dose of a placebo syrup, according to the same schedule used for the children in the A group

  3. Grpup III: vitamin A + zinc. Supplementation with both vitamin A and zinc

  4. Group IV: placebo

Outcomes Vibriocidal antibody response to cholera vaccine
Notes No clinical outcomes were available so no data were included in meta‐analysis
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "Bottles of syrup were serially numbered according to the randomizations list"
Comment: most likely done
Allocation concealment (selection bias) Low risk Quote: "The randomizations code was broken after completion of the study"
Blinding (performance bias and detection bias) 
 Blinding of Participants Low risk Quote: "The zinc syrup and its placebo syrup looked very similar, as did the vitamin A syrup and its placebo syrup."
Blinding (performance bias and detection bias) 
 Blinding of provider Low risk Quote: "The randomization code was broken after completion of the study"
Blinding (performance bias and detection bias) 
 Blinding of outcome assessor Low risk Quote: "The randomization code was broken after completion of the study"
Incomplete outcome data (attrition bias) Low risk Comment: minimal attrition
Selective reporting (reporting bias) Unclear risk Comment: no trial registration number was available
Other bias Low risk Comment: this study seems to be free of other bias